1-2 of 2
Akif Yesilipek
Close
Sort by
Journal Articles

Low rate of nonrelapse mortality in under-4-year-olds with ALL given chemotherapeutic conditioning for HSCT: a phase 3 FORUM study

Clinical Trials & Observations
Peter Bader, Ulrike Pötschger, Jean-Hugues Dalle, Laura M. Moser, Adriana Balduzzi, Marc Ansari, Jochen Buechner, Tayfun Güngör, Marianne Ifversen, Gergely Krivan, Herbert Pichler, Marleen Renard, Raquel Staciuk, Petr Sedlacek, Jerry Stein, Jan Robert Heusel, Tony Truong, Jacek Wachowiak, Akif Yesilipek, Franco Locatelli, Christina Peters
Journal: Blood Advances
Blood Adv (2024) 8 (2): 416–428.
https://doi.org/10.1182/bloodadvances.2023010591
Published: 2024
Includes: Supplemental data
Journal Articles

Allogeneic hematopoietic stem cell transplantation in leukocyte adhesion deficiency type I and III

Clinical Trials & Observations
Shahrzad Bakhtiar, Emilia Salzmann-Manrique, Henric-Jan Blok, Dirk-Jan Eikema, Sheree Hazelaar, Mouhab Ayas, Amos Toren, Gal Goldstein, Despina Moshous, Franco Locatelli, Pietro Merli, Gerard Michel, Gülyüz Öztürk, Ansgar Schulz, Carsten Heilmann, Marianne Ifversen, Rob F. Wynn, Olga Aleinikova, Yves Bertrand, Abdelghani Tbakhi, Paul Veys, Musa Karakukcu, Alphan Kupesiz, Ardeshir Ghavamzadeh, Rupert Handgretinger, Emel Unal, Antonio Perez-Martinez, Muge Gokce, Fulvio Porta, Tekin Aksu, Gülsün Karasu, Isabel Badell, Per Ljungman, Elena Skorobogatova, Akif Yesilipek, Tsila Zuckerman, Robbert R. G. Bredius, Polina Stepensky, Bella Shadur, Mary Slatter, Andrew R. Gennery, Michael H. Albert, Peter Bader, Arjan Lankester
Journal: Blood Advances
Blood Adv (2021) 5 (1): 262–273.
https://doi.org/10.1182/bloodadvances.2020002185
Published: 2021
Includes: Supplemental data